Ambu A/S (OTCMKTS:AMBBY) Shares Gap Up – Here’s What Happened

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) gapped up before the market opened on Wednesday. The stock had previously closed at $10.2250, but opened at $11.64. Ambu A/S shares last traded at $11.64, with a volume of 100 shares.

Wall Street Analysts Forecast Growth

Separately, UBS Group downgraded Ambu A/S from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 15th. One analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the stock presently has an average rating of “Hold”.

Ambu A/S Stock Up 5.8%

The business’s 50 day simple moving average is $10.85 and its 200-day simple moving average is $10.38. The company has a market cap of $2.74 billion, a price-to-earnings ratio of 38.80 and a beta of 0.93. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.69 and a current ratio of 2.77.

Ambu A/S (OTCMKTS:AMBBY) last posted its quarterly earnings results on Tuesday, August 25th. The company reported $0.09 EPS for the quarter. Ambu A/S had a net margin of 8.18% and a return on equity of 8.49%. The business had revenue of $255.12 million for the quarter.

About Ambu A/S

Ambu A/S is a Danish medical device company that develops, manufactures and markets single-use products for hospitals, clinics and emergency care providers. Its portfolio includes disposable endoscopes and visualization systems used in areas such as bronchoscopy, gastrointestinal procedures, urology, ear, nose and throat care, and anesthesia.

The company also supplies products for airway management, patient monitoring and emergency care, including electrodes, resuscitation equipment and training manikins.